CHAPTER 3 Death and Survival on Dialysis

Slides:



Advertisements
Similar presentations
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Advertisements

This Power Point presentation belongs to the Danish Renal Registry, which owns the copyright. It can be freely used for non-commercial study and educational.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
CHAPTER 12 Peritoneal Dialysis Sunita Bavanandan Lily Mushahar Anita Bhajan Manocha Source: 20 th MDTR Report 2012, NRR.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
UK Renal Registry 9 th Annual Report 2006 Fig 9.1 Percentage of patients with serum phosphate
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
CHAPTER 6: MANAGEMENT OF ANAEMIA IN PATIENTS ON DIALYSIS Philip N. Jeremiah Bee Boon Cheak Ghazali B Ahmad Lim Soo Kun Zawawi B Nordin Source: 21 st MDTR.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.
CHAPTER 8: Blood Pressure Control and Dyslipidaemia in Patients on Dialysis S. Prasad Menon Hooi Lai Seong Lee Wan Tin Sunita Bavanandan Source: 21 st.
CHAPTER 11 Haemodialysis Practices Tan Chwee Choon Shahnaz Shah Firdaus Khan Rafidah Abdullah Norleen Bt Zulkarnain Sim Source: 20 th MDTR Report 2012,
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
What happens to patients returning to dialysis after transplant failure? Data from the UK Renal Registry Dr Lynsey Webb 1, Dr Anna Casula 1, Dr Charlie.
Chapter 3 Death and Survival on Dialysis Wong Hin Seng Ong Loke Meng Source: 20 th MDTR Report 2012, NRR.
CHAPTER 8: BLOOD PRESSURE CONTROL AND DYSLIPIDAEMIA S. Prasad Menon Hooi Lai Seong Lee Wan Tin Sunita Bavanandan Source: 20 th MDTR Report 2012, NRR.
Table S1. Logistic regression analysis for the variables associated with the degree of change in cTnT between 2 time points (n=89) UnivariateMultivariate.
Stephen P. McDonald, Graeme R. Russ  Kidney International 
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
UK Renal Registry 18th Annual Report
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
1.08 (0.77, 1.51) 0.93 (0.74, 1.16) 0.84 (0.63, 1.12) 1.29 (0.24, 6.91) 1.10 (0.80, 1.52) 0.93 (0.74, 1.17) 1.50 (0.27, 8.34) 1.12 (0.39, 3.23) 0.81 (0.60,
UK Renal Registry 10th Annual Report 2007
Copyright © 2011 American Medical Association. All rights reserved.
Mortality rates in incident ESRD patients figure 9
Fig 7.1 Median URR achieved in each renal unit
UK Renal Registry 16th Annual Report
UK Renal Registry 18th Annual Report
Copyright © 2007 American Medical Association. All rights reserved.
CHAPTER 5 Paediatric Renal Replacement Therapy
Table 4.1: Cumulative distribution of QoL-Index score in relation to dialysis modality, all dialysis patients
CHAPTER 7 Nutritional Status on Dialysis
CHAPTER 11: Haemodialysis Practices
Volume 86, Issue 5, Pages (November 2014)
CHAPTER 3 DEATHS Stephen McDonald 2012 Annual Report—35th Edition
CHAPTER 9 Chronic Kidney Disease – Mineral and Bone Disorder
Christopher Lim Thiam Seong
CHAPTER 10 Hepatitis on Dialysis
Volume 88, Issue 2, Pages (August 2015)
UK Renal Registry 14th Annual Report
Volume 76, Issue 10, Pages (November 2009)
Cause Specific Death Rates for All Dialysis Patients
Volume 80, Issue 10, Pages (November 2011)
Volume 77, Issue 7, Pages (April 2010)
2013 Annual Report - 36th Edition
Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.
Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States  George A. Kaysen, MD, PhD, Kirsten.
Chapter 7 Nutritional status on dialysis
UK Renal Registry 14th Annual Report
Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 74, Issue 8, Pages (October 2008)
K. Kalantar-Zadeh, J. D. Kopple, N. Kamranpour, A. M. Fogelman, M
Areef Ishani, Allan J. Collins, Charles A. Herzog, Robert N. Foley 
Thiazolidinedione use is associated with better survival in hemodialysis patients with non-insulin dependent diabetes  Steven M. Brunelli, Ravi Thadhani,
Volume 61, Issue 2, Pages (February 2002)
E.F. Vonesh, J.J. Snyder, R.N. Foley, A.J. Collins 
Yu–Xiao Yang, Sean Hennessy, James D. Lewis  Gastroenterology 
CHAPTER 10 Hepatitis on Dialysis
Figure Prevalence of coronary artery disease by year or
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

CHAPTER 3 Death and Survival on Dialysis

Table 3.1.1: Deaths on dialysis 2007-2016

Figure 3.1.1: Death rates on dialysis 2007-2016

Table 3.1.2: Causes of death on dialysis, 2007-2016

Table 3.2.1(a): Patient survival by dialysis modality [ITT analysis (not censored for change of modality)]

Figure 3.2.1: Patient survival by dialysis modality analysis (not censored for change of modality)

Table 3.2.2: Unadjusted patient survival by age

Figure 3.2.2: Unadjusted patient survival by age

Table 3.2.3: Unadjusted patient survival by diabetes mellitus status

Figure 3.2.3: Unadjusted patient survival by diabetes mellitus status

Table 3.2.4: Unadjusted patient survival by 4 Era, 1996-2016

Figure 3.2.4(a): Unadjusted patient survival by 4 Era, 1996-2016

Figure 3.2.4(b): Adjusted for Age and Diabetes patient survival by 4 Era, 1996-2016

Figure 3.3.1(a): Variation in patient survival at 1-year among HD centres adjusted for age and diabetes mellitus status, 2007-2015

Figure 3.3.1(b): Funnel plot at 1-year among HD centres adjusted for age and diabetes mellitus status, 2007-2015 cohort

Figure 3.3.1(c): Variation in patient survival at 5-years among HD centres adjusted for age and diabetes mellitus status, 2007-2011

Figure 3.3.1(d): Funnel plot for patient survival at 5-years among HD centres adjusted age and diabetes mellitus, 2007-2011 cohort

Figure 3.3.2(a): Variation in patient survival at 1-year among PD centres adjusted for age and diabetes mellitus, 2007-2015

Figure 3.3.2(b): Funnel plot at 1-year among PD centres adjusted for age and diabetes mellitus status, 2007-2015 cohort

Figure 3.3.2(c): Variation in patient survival at 5-years among PD centres adjusted for age and diabetes mellitus, 2007-2011

Figure 3.3.2(d): Funnel plot for patient survival at 5-years among PD centres adjusted age and diabetes mellitus, 2007-2011 cohort

Table 3.4.1: Adjusted hazard ratio for mortality of dialysis patients uncensored for change of modality (1996-2016)

Figure 3.4.1(a): Adjusted hazard ratio for mortality of dialysis patients uncensored for change of modality by diastolic blood pressure (1996-2016 cohort)

Figure 3.4.1(b): Adjusted hazard ratio for mortality of dialysis patients uncensored for change of modality by hemoglobin (1996-2016 cohort)

Figure 3.4.1(c): Adjusted hazard ratio for mortality of dialysis patients uncensored for change of modality by serum phosphate (1996-2016 cohort)

Table 3.4.2: Adjusted hazard ratio for mortality of HD patients [ITT analysis] (1996-2016 cohort)

Figure 3.4.2: Adjusted hazard ratio for mortality of HD patients uncensored for change of modality by Kt/V (1996-2016 cohort)

Table 3.4.3: Adjusted hazard ratio for mortality of PD patients [ITT analysis] (1996-2016 cohort)

Figure 3.4.4(a): Variations in RAMR by HD centre, 2015

Figure 3.4.4(b): Funnel plot of RAMR by HD centre, 2015

Figure 3.4.5(a): Variations in RAMR by PD centres, 2015

Figure 3.4.5(b): Funnel plot for RAMR by PD centres, 2015